Endocrine alterations in kidney transplant patients

Area of Science:

• Nephrology
• Endocrinology
• Immunology

Background:

• Endocrine system dysfunctions are common in patients with chronic kidney disease.
• Renal transplantation aims to restore kidney function but can lead to persistent endocrine alterations.
• Immunosuppressive therapy post-transplantation can further influence hormonal balance.

Purpose of the Study:

• To identify and describe the persistent endocrine alterations observed after renal transplantation.
• To explore the contributing factors to these post-transplant endocrine changes.
• To highlight the specific hormonal abnormalities and their potential clinical implications.

Main Methods:

• Review of existing literature on endocrine function in renal transplant recipients.
• Analysis of factors influencing hormone secretion, transport, and target organ response.
• Description of specific endocrine abnormalities based on clinical observations and studies.

Main Results:

• Persistent endocrine abnormalities include disrupted aldosterone-renin relationship, abnormal vasopressin regulation, suppressed cortisol response, secondary hyperparathyroidism, insulin deficiency, and altered gastrointestinal and natriuretic peptide hormone secretion.
• Factors contributing to these alterations include pre-transplant uremia duration, native kidney function, graft quality, and immunosuppressive drugs (glucocorticoids, azathioprine, cyclosporin A).
• Acute graft rejection episodes present endocrine changes similar to those in renal failure.

Conclusions:

• Renal transplantation does not always fully resolve endocrine disturbances.
• A complex interplay of factors, including graft status and immunosuppression, perpetuates endocrine alterations.
• Monitoring and management of endocrine health are crucial in renal transplant recipients.